Treatment for advanced breast cancer with brain metastases

被引：0
|
作者：
Yan, Min [1 ,2 ]
Yang, Jin [3 ]
机构：
[1] Zhengzhou Univ, Affiliated Canc Hosp, Henan Breast Canc Ctr, Zhengzhou 450008, Henan, Peoples R China
[2] Henan Canc Hosp, Zhengzhou, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Canc Ctr, Xian, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
tyrosine kinase inhibitor; monoclonal antibody; antibody-drug conjugate; breast cancer; brain metastases;
D O I：
10.3389/fonc.2023.1268702
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Brain metastases of breast cancer
    Melisko, ME
    Kunwar, S
    Prados, M
    Berger, MS
    Park, JW
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (02) : 253 - 268
  • [32] Advances in the management of breast cancer brain metastases
    Sammons, Sarah
    Van Swearingen, Amanda E. D.
    Chung, Caroline
    Anders, Carey K.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 : V63 - V74
  • [33] Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: The role of Rad51
    Sosinska-Mielcarek, Katarzyna
    Duchnowska, Renata
    Winczura, Piotr
    Badzio, Andrzej
    Majewska, Hanna
    Lakomy, Joanna
    Peksa, Rafal
    Pieczynska, Beata
    Radecka, Barbara
    Debska, Sylwia
    Biernat, Wojciech
    Jassem, Jacek
    BREAST, 2013, 22 (06) : 1178 - 1183
  • [34] Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts
    Bartolotti, Marco
    Franceschi, Enrico
    Brandes, Alba A.
    FUTURE ONCOLOGY, 2013, 9 (11) : 1653 - 1664
  • [35] Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases
    Puri, Akshjot
    Mylavarapu, Charisma
    Xu, Jiaqiong
    Patel, Tejal A.
    Teh, Bin S.
    Tremont-Lukats, Ivo
    Chang, Jenny C.
    Niravath, Polly
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (03) : 613 - 623
  • [36] Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases
    Akshjot Puri
    Charisma Mylavarapu
    Jiaqiong Xu
    Tejal A. Patel
    Bin S.Teh
    Ivo Tremont-Lukats
    Jenny C. Chang
    Polly Niravath
    Breast Cancer Research and Treatment, 2022, 193 : 613 - 623
  • [37] Challenges in the treatment of breast cancer brain metastases: evidence, unresolved questions, and a practical algorithm
    Meattini, I.
    Andratschke, N.
    Kirby, A. M.
    Sviri, G.
    Offersen, B. V.
    Poortmans, P.
    Person, O. Kaidar
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (10) : 1698 - 1709
  • [38] Multiple brain metastases after breast cancer and their radiotherapy management: what is the optimal treatment?
    Kirova, Youlia M.
    Chargari, Cyrus
    Mazeron, Jean-Jacques
    BULLETIN DU CANCER, 2011, 98 (04) : 409 - 415
  • [39] Systemic treatment of brain metastases from breast cancer: cytotoxic chemotherapy and targeted therapies
    Bachelot, Thomas
    Le Rhun, Emilie
    Labidi-Gally, Intidar
    Heudel, Pierre
    Gilabert, Marine
    Bonneterre, Jacques
    Pierga, Jean-Yves
    Goncalves, Anthony
    BULLETIN DU CANCER, 2013, 100 (01) : 7 - 14
  • [40] Gamma knife radiosurgery and neurosurgical treatment management for breast cancer patients with brain metastases
    van Eck, ATCJ
    Ulrich, F
    Baltzer, J
    Horstmann, GA
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2004, 64 (01) : 63 - 69
12345